The immune function in cancer patients is suppressed, however, the factors that promote this suppression are still obscured. We hypothesized that polyamine is one of the causative factors of the immune suppression, as polyamine levels in blood and tissues are increased in cancer patients.
Introduction
The immune suppression is often observed in cancer patients. Many alterations in immune function, such as impaired cytokine production, attenuated adhesion characteristics of peripheral blood mononuclear cells (PBMCs), and decreased cytotoxic activities of killer cells, are reported (Heriot, Marriott et al., 2000; Shirai, Watanabe et al., 1990; Blindar' and Zubrikhina 1998; Hersh, Gschwind et al., 1982) . The mechanism of the immune suppression is considered due to the increased production of the immunosuppressive factors from cancer tissue; however, these factors are not fully characterized yet.
The natural polyamines putrescine, spermidine, and spermine are ubiquitous polycations found in every living cell. Their biosynthesis is active in cells of which growth is active, such as cancer cells, and the elevated levels of polyamine in cancer tissues in comparison to those of normal surrounding tissues have been reported (Loser, Folsch et al. 1990; Linsalata, Russo et al., 1993; Canizares, Salinas et al., 1999) . It has been believed that polyamines are synthesized in cells as needed, however, recent studies have brought to light the importance of polyamines from extracellular sources. The polyamine concentration of red blood cells and white blood cells is increased in cancer patients, and the increase was considered due to the polyamine uptake by blood cells from cancer cells (Nishiguchi, Tamori et al. 2002; Cooper, Shukla et al., 1978; Moulinoux, Quemener et al.,1989) . Similarly, cultured white blood cells have been shown their capability of taking up polyamines from culture media (Zhang, Borovikova, et al. 1999; Walters and Wojcik 1994) .
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The increase in polyamine concentrations in leukocyte of cancer patients dramatically reduced when tumors are removed (Uehara, Shirakawa et al., 1980) ). One interesting findings is that altered immune functions are sometimes 'normalized' when a tumor is removed (Rampone, Rampone et al. (2001) . Here, we examine the immunomodulatory effects of polyamines on peripheral blood mononuclear cells (PBMCs) by adding polyamines directly in the absence of enzymes that oxidize polyamines and produce cytotoxic substances.
Materials and Methods
Isolation and preparation of peripheral blood mononuclear cells (PBMCs)
Human PBMCs from healthy volunteers were isolated by density gradient centrifugation using separate-L (Muto Pure Chemicals Co. LTD., Tokyo, Japan). PBMCs were re-suspended in RPMI-1640, supplemented with 10% heat-inactivated human serum AB (Wako Pure Chemical Industries LTD., Osaka, Japan), 0.1% L-glutamine (Invitrogen Corp., CA, USA), and 0.01% Penicillin-Streptomycin (Invitrogen). Spermine (spermine tetrahydrochloride), spermidine (spermidine trihydrochloride), or putrescine (1, 4-butanediamine dihydrochloride) (Wako Pure Chemical) was added to human PBMCs at various concentrations.
TNF induction and assay
Escherichia coli endotoxin (LPS; Sigma Chem. Co., MO, USA) was added to a final concentration of 100ng/ml to stimulate TNF production from cultured human PBMCs. Freshly prepared spermine, spermidine, or putrescine was added to human PBMCs cultured in 96-well at various concentrations 1 hour before LPS stimulation.
Four hours after LPS stimulation, supernatants were harvested.
TNF levels were supernatants and standard hTNF solution was added to each well in triplicate. After 2
hours of incubation at room temperature, the ELISA plate was washed 3 times with wash ANNALS OF Cancer Research and Therapy of substrate reagent was added to each well for the enzymatic color reaction. After the reaction was stopped with a stop solution, the plates were read using a single wavelength (450nm) on an automated EIA analyzer (Titertek Multiskan, Flow Laboratories Inc).
Adhesion and Cell Viability Assays
Freshly prepared spermine, spermidine, or putrescine at various concentrations was added to human PBMCs cultured in 96-well. PBMCs were cultured for 24 to 80 hours and were gently washed 3 times with PBS (-) using a multi-pipetter, and non-adherent cells were removed. To estimate the cell viability and activities of whole cultured cells, the culture plate was centrifuged, and culture medium was gently aspirated. 0.35mg/ml
was added to the culture media and cultured for 3 to 4 hours. After color change was was added to the wells. The absorption at 570nm and 690nm was determined with an automated EIA analyzer (Titertek Multiskan, Flow Laboratories Inc). Trypan blue exclusion was also used to evaluate cytotoxicity of polyamines.
Cytotoxicity Assay
The cytolytic activity of Lymphokine-Activated-Killer (LAK) cells was measured in a standard 3.5-hour 51Cr-release assay using Daudi cells as target cells. After removing the extra-cellular polyamines by washing, PBMCs were re-suspended in interleukin-2 (IL-2) was added to the PBMCs at a concentration of 25units/ml, and the cells were cultured for 72 hours. Daudi cells labeled with 51Cr were co-cultured with PBMCs for 3.5 hours (E/T ratio=1), then radioactivity in the supernatant was measured.
Statistical analysis
The data from the analyses of TNF production in culture medium, adhesion to plastic plate, and cytotoxic activities were expressed as a percentage of control cells, i. e.
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Results
Spermine and spermidine, but not putrescine, suppressed TNF production upon LPS stimulation To study the effect of spermine, spermidine, and putrescine on TNF production, human PBMCs were stimulated with LPS (100ng/ml). Pretreatment (60min before LPS challenge) with spermine and spermidine decreased TNF production of PBMCs in a TNF synthesis (p<0.05). However, putrescine did not decrease TNF production even concentration of putrescine (1mM) slightly decreased TNF production (p=0.041), however, the inhibitory effects of putrescine on TNF synthesis seemed not apparent.
Spermine and spermidine did not interfere with ELISA detection of TNF as evidenced by the fact that TNF standard curves measured in the presence of spermine and spermidine were comparable to TNF standard curve generated in their absence.
Spermine and spermidine, but not putrescine decreased adhesion characteristics Three days culture with spermine effectively weakened the capacity of human PBMCs to adhere to plastic plate, in a dose-dependent manner (Figure 2 ). The decrease in adhesion characteristics by spermine was not due to decreased cell viability or activity.
When a 96-well culture plate, in which PBMCs were cultured for 72 hours with polyamines, was centrifuged to adhere all cultured cells to the culture plate, the experiments of the metabolism of MTT showed no decrease in cell activities on PBMCs (Figure 2) . Separate experiments using trypan blue exclusion also confirmed that spermine concentrations of up to 1mM were not toxic for up to 80 hours (data not shown).
Seventy-two hours culture with spermidine also weakened the capacity of human PBMCs to adhere to plastic plate, in a dose-dependent manner (Figure 3 ). The effects of spermine on the decrease of adhesion characteristics seemed more potent than those of spermidine. However, no such effect was observed with putrescine, even when PBMCs were cultured with 1mM of putrescine for up to 80 hours (Figure 3 ) . The decrease of LAK activities by spermine was observed in a spermine dose-dependent lower (p<0.05) than those of control cells (PBMCs cultured overnight with no polyamine) .
Discussion
We showed that spermine and spermidine inhibited some of the cellular functions closely related to the anti-cancer immunity such as the production of cytotoxic cytokine, cell adhesion, and cytotoxic activities of lymphokine activated killer (LAK) cells. These effects were not due to decreased cell viability or activity as the experiment using whole cultured cells confirmed that spermine and spermidine were not toxic. In earlier studies regarding the effects of polyamines on immune functions, many immunomodulatory effects were found to be likely caused by cytotoxic substances derived from the polyamines oxidation by amine oxidases contained in the culture medium (Byrd, Jacobs et al., 1977) . However, in our study, we examine the cellular function by adding polyamines directly, in the absence of enzymes that oxidize polyamines and produce cytotoxic substances.
The production of TNF upon stimulation is important for the killing of tumor cells and microbial organisms. Some reports have shown that, in cancer patients, the ability to produce several cytokines that are needed for cytotoxic activities of immune cells is impaired (Hersey, Edwards et al., 1982; Rey, Klein et al, 1983; Monson, Ramsden et aL, 1986) . As shown in our previous report and by others, the decrease of TNF production became profound as the cancer progression. (Soda, Satake et al., 1994; Heriot, Marriott et ANNALS OF Cancer Research and Therapy al., 2000) Spermine and spermidine have been shown to decrease the production of TNF and other pro-inflammatory cytokines from cultured human PBMCs, while they do not suppress the production of anti-inflammatory cytokine, TGF-b (Zhang, Caragine et al., 1997) . Quite interestingly, in cancer patients, the productions of anti-inflammatory cytokines are reported to be higher than those of non-cancer patients (Twardzik, Sherwin et al., 1982) .
Many previous reports have shown that leukocyte from cancer patients lack adhesion capacity to tumor cells as well as to culture plates (Blindar' and Zubrikhina 1998; Hersh, Gschwind et al., 1982) . The first step of the mechanism of tumor cell cytolysis by killer cells is target cell binding. Therefore, the characteristics of decreased adhesion were considered as one of the mechanisms that hinder the anti-tumor immunity in cancer patients. In fact, augmentation of the expression of molecules required for cell adhesion successfully enhanced cytotoxicity of killer cells, and vise versa (Aramburu, Balboa et al., 1993; Timonen, Gahmberg et al., 1990; Webb, Mostowski et al., 1991) . The culture of human PBMCs with IL-2 results in the generation of cytotoxic cells, namely LAK cells, which are able to lyse autologous tumor cells that cannot be lysed by untreated natural killer cells. However, the killer cell activities of activated lymphocytes from cancer patients are sometimes decreased (Pisani, Krco et al., 1989 , Shirai, Watanabe et al., 1990 .
Overnight culture with spermine and spermidine successfully suppressed LAK cell cytotoxicities without decreasing cell activities or viabilities.
In the present study, we showed that some of the changes in immune functions in cancer patients could be observed by adding polyamines to cultured human PBMCs. In addition, previous studies have shown that polyamines decrease IL-2 production from monocytes and macrophages. The decrease in IL-2 production in cancer patients is documented in many previous reports (Hersey, Bindon et al., 1983; Monson, Ramsden et al., 1986; Rey , Klein et al., 1983) . Therefore, the increase in polyamine synthesis in cancer tissues may be responsible for the suppression of cellular immunity in cancer patients.
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